Acute-onset endophthalmitis after cataract surgery: Success of initial therapy, visual outcomes, and related factors

Retina

Volumn 29, Issue 5, 2009, Pages 606-612

  Altan, Tugrul ^a,c   Acar, Nur ^a   Kapran, Ziya ^a   Unver, Yaprak Banu ^a   Yurttaser, Serap ^a   Küçüksümer, Yaşar ^a   Eser, Ilker ^b  

^a Beyoglu Eye Research and Training Hospital   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c Konaklar Mah   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOXITIN; CEFTAZIDIME; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SILICONE OIL; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CATARACT EXTRACTION; CENTRAL RETINA VEIN OCCLUSION; CHOROID HEMORRHAGE; CILIARY DISK; CONTROLLED STUDY; CORNEA EDEMA; CORNEA OPACITY; EARLY INTERVENTION; ENDOPHTHALMITIS; EXTRACAPSULAR CATARACT EXTRACTION; FEMALE; GRAM NEGATIVE BACTERIUM; HAND MOVEMENT; HUMAN; INTRACAPSULAR CATARACT EXTRACTION; INTRAOCULAR PRESSURE; IRIS RUBEOSIS; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHACOEMULSIFICATION; POSTOPERATIVE INFECTION; REOPERATION; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; TRABECULECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY; ACUTE DISEASE; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; PNEUMOCOCCAL INFECTION; POSTOPERATIVE COMPLICATION; PSEUDOMONAS INFECTION; RISK FACTOR;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CATARACT EXTRACTION; ENDOPHTHALMITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POSTOPERATIVE COMPLICATIONS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 66349109711     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181953a31     Document Type: Article

References (26)

1. Li J, Morlet N, Ng JQ, Semmens JB, Knuiman MW, Team EPSWA. Significant nonsurgical risk factors for endoph-thalmitis after cataract surgery: EPSWA fourth report. Invest Ophthalmol Vis Sci 2004;45:1321-1328.
2. Morlet N, Li J, Semmens JB, Ng J, Team EPSWA. The Endophthalmitis Population Study of Western Australia (EPSWA): first report. Br J Ophthalmol 2003;87:574-576.
3. Kattan HM, Flynn HW Jr, Pflugfelder SC, Robertson C, For-ster RK. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 1991;98:227-238.
4. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction. Endophthalmitis following inpatient surgery. Arch Ophthalmol 1991;109:1085-1089.
5. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007;33:978-988.
6. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol 1998;43:193-224.
7. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2002; 28:977-981.
8. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113:1479-1496.
9. Kent DG. Endophthalmitis in Auckland 1983-1991. Aust N Z J Ophthalmol 1993;21:227-236.
10. Lertsumitkul S, Myers PC, O'Rourke MT, Chandra J Endophthalmitis in the western Sydney region: a case-control study. Clin Experiment Ophthalmol 2001;29:400-405.
11. Weber DJ, Hoffman KL, Thoft RA, Baker AS. Endophthalmitis following intraocular lens implantation: report of 30 cases and review of the literature. Rev Infect Dis 1986;8:12-20.
12. Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol 1997;32:303-310.
13. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122:830-846.
14. Montan P, Lundstrom M, Stenevi U, Thorburn W. Endophthalmitis following cataract surgery in Sweden: the 1998 National Prospective Survey. Acta Ophthalmol Scand 2002;80:258-261.
15. Kamalarajah S, Silvestri G, Sharma N, et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye 2004;18:580-587.
16. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-1010.
17. Anand AR, Therese KL, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 2000;48:123-128.
18. Kunimoto DY, Das T, Sharma S, et al. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 1999;128:240-242.
19. Bohigian GM, Olk RJ. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol 1986;101:332-341.
20. Wong TY, Chee SP. The epidemiology of acute endophthalmitis after cataract surgery in an Asian population. Ophthalmology 2004;111:699-705.
21. Eser I, Altan T, Stahl JE, et al. Two cases of Burkholderia cepacia endophthalmitis. Br J Ophthalmol 2006;90:1211.
22. Durand ML. The post-endophthalmitis vitrectomy study era (letter). Arch Ophthalmol 2002;120:233-234.
23. Morlet N, Graham GG, Gatus B, et al. Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis. Antimicrob Agents Chemother 2000;44:1674-1679.
24. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol 2003;121:345-350.
25. Shah GK, Stein JD, Sharma S, et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000;107:486-489.
26. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by iso-genic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci 1995;36:9-15.